CUE peer analysis
Cue Biopharma (CUE) against its competitors: price, today's move, 1-year return and market value side by side.
CUE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| EQ Equillium | $1.15 | -10.85% | 10.58% | $94.67M |
| IPSC Century Therapeutics | $1.36 | -17.07% | 189.01% | $247.88M |
| MDCX Medicus Pharma | $1.69 | -13.33% | -98.46% | $2.42M |
| NRXP NRX Pharmaceuticals | $2.53 | 17.67% | 1.61% | $110.42M |
| OTLK Outlook Therapeutics | $0.37 | -7.22% | -76.80% | $88.66M |
| SNTI Senti Biosciences | $0.10 | -27.28% | -93.78% | $3.12M |
| SPRB Spruce Biosciences | $40.25 | -4.73% | -61.96% | $116.25M |
| CUE Cue Biopharma | $3.11 | -77.94% | -83.60% | $25.91M |
- CUE's peers: EQ (Equillium), IPSC (Century Therapeutics), MDCX (Medicus Pharma), NRXP (NRX Pharmaceuticals), OTLK (Outlook Therapeutics), SNTI (Senti Biosciences), SPRB (Spruce Biosciences).
Updated 2026-11-18 05:48 UTC